Skip to main content
Andrzej Jakubowiak, MD, Oncology, Chicago, IL

Andrzej J Jakubowiak MD

Oncology•Chicago, IL

Hematologic Oncology

Professor, Medicine, University of Chicago Div of the Bio Sci The Pritzker SOM

Join to view full profile

  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-702-9268

Dr. Jakubowiak is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Jakubowiak's full profileAlready have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1994 - 1997
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1992 - 1992
  • University of Medical Science Poznan
    University of Medical Science PoznanClass of 1977

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2026
  • NC State Medical License
    NC State Medical License 2021 - 2022
  • MI State Medical License
    MI State Medical License 2000 - 2013
  • NY State Medical License
    NY State Medical License 1997 - 2000

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Andrzej Jakubowiak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)_CD3 Bispecific Antibody, in P...
    Andrzej Jakubowiak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
    Andrzej Jakubowiak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Split First Dose Administration of Daratumumab for the Treatment of Patients with Multiple Myeloma (MM): Clinical Pharmacology and Population Pharmacokinetic (PK) Anal... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaDecember 2017
  • Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaDecember 2017
  • Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated MyelomaDecember 2017

Press Mentions

  • More Than 100 UChicago Medicine Physicians Named to Chicago Magazine’s ‘Cancer Fighters’ List
    More Than 100 UChicago Medicine Physicians Named to Chicago Magazine’s ‘Cancer Fighters’ ListJanuary 22nd, 2026
  • Five Under 5: Top Oncology Videos for the Week of 11/9 | OncLive
    Five Under 5: Top Oncology Videos for the Week of 11/9 | OncLiveNovember 16th, 2025
  • Cancer Survivor Encourages Black Patients to Enroll in Clinical Trials
    Cancer Survivor Encourages Black Patients to Enroll in Clinical TrialsSeptember 26th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Andrzej Jakubowiak, Dr. Andrzej Jakubowiak, MD, Dr. A Jakubowiak, Dr. Andrzej J Jakubowiak